Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Organ transplantation stories

Oct 23, 2026

Tegoprubart outperforms tacrolimus in preserving kidney function after transplant, BESTOW trial finds

The Phase 2 BESTOW clinical trial demonstrated that tegoprubart, a novel anti-CD40L antibody therapy, was superior to tacrolimus, the current standard of care, at preserving kidney function in adults receiving their first kidney transplant. The trial results suggest a potential advancement in immunosuppressive treatment regimens for transplant patients.

Oct 23, 2026·3 sources
00
Oct 20, 2026

Katherine Screws' 3-year wait for intestine transplant highlights complexity of US organ system

Katherine Screws, a Phoenix woman whose small intestine was destroyed in a car crash, waited three years for an intestine transplant while dependent on IV nutrition. She was among just 88 people in the U.S. to receive an intestine transplant last year, illustrating the challenges and complexity of the organ transplant system for rare procedures.

Oct 20, 2026·4 sources
00
Sep 3, 2026

Pig kidney keeps New Hampshire man alive for record 271 days before human transplant

Tim Andrews, a 66-year-old New Hampshire man with kidney failure, survived a record 271 days with a genetically modified pig kidney before receiving a human donor transplant. The case represents the first reported example of a pig kidney successfully serving as a bridge to human transplantation.

Sep 3, 2026·5 sources
00
Aug 10, 2026

Spatial transcriptomics reveals molecular programs linked to heart-transplant rejection

Researchers at Vanderbilt Health have published findings in Nature Cardiovascular Research showing that spatial transcriptomics of cardiac biopsies reveals significant cellular and molecular variation in transplant rejection that is not captured by conventional biopsy grading, potentially enabling precision medicine approaches to organ rejection treatment.

Aug 10, 2026·4 sources
00
Jul 30, 2026

Medical University of Vienna develops new treatment enabling kidney transplant for previously ineligible patient

An international research team led by the Medical University of Vienna has reported a breakthrough treatment strategy that successfully enabled a kidney transplant for a patient who had no realistic chance of receiving a suitable donor organ through conventional methods.

Jul 30, 2026·1 source
00
Jul 28, 2026

Remdesivir treatment reduces cardiovascular complications in kidney transplant recipients with COVID-19

Study finds that kidney transplant recipients treated with remdesivir within a week of COVID-19 diagnosis and receiving at least three consecutive days of therapy experienced fewer cardiovascular complications compared to those who did not receive the antiviral treatment.

Jul 28, 2026·1 source
00
Jul 8, 2026

Northwestern Medicine study shows lung transplants can extend survival for patients with advanced lung cancer

A landmark study from Northwestern Medicine published July 8, 2026, demonstrates that lung transplants can successfully extend survival for select patients with Stage 4 lung cancer that hasn't spread beyond the lungs, challenging the long-held belief that transplanting organs into advanced cancer patients is too risky.

Jul 8, 2026·4 sources
00
Apr 17, 2026

First-in-Human Trial Shows Liver Transplant Patients Can Stop Immunosuppressants After Cell Therapy

UPMC and University of Pittsburgh researchers successfully weaned multiple liver transplant patients off all immunosuppressant drugs for over three years using a pre-transplant cell therapy approach, representing a potential breakthrough in organ transplantation.

Apr 17, 2026·2 sources
00

Top claims

  • ▪In a separate Breakthrough T1D-funded study testing tegoprubart with deceased-donor islet transplants, all 12 enrolled participants were able to stop external insulin therapy.
  • ▪In the BESTOW trial, kidney graft function stabilized after the first month and demonstrated a statistically significant benefit for tegoprubart over tacrolimus at 18 months.
  • ▪Tacrolimus is current standard-of-care transplant immunosuppressive therapy that prevents organ rejection but carries toxicity and side effects including hypertension, diabetes, tremors, and brain fog.

Subtopics

Drug Approval and Clinical Trials5Drug Policy, Pricing & Approval5Immunology3Clinical trials2Mental breakthroughs2Antiviral therapy1Biomedical research1Biotech innovation1Cardiovascular health.1Clinical evaluation1Clinical Trial Design & Evaluation1Critical injury1Digestive diseases1Drug development1Genetic engineering1Healthcare system1Infectious Disease and Outbreaks1Precision medicine1Randomized controlled trial1Rare diseases1Regenerative medicine1Renal system1Science1Spatial transcriptomics1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories